Dogwood Therapeutics DWTX Total Current Liabilities
Total Current Liabilities at other companies
Other financials
Where this comes from
Reported directly by Dogwood Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:LiabilitiesCurrent.
The official record: Dogwood Therapeutics’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →
Ask your AI about Dogwood Therapeutics's total current liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Dogwood Therapeutics's total current liabilities?
- Dogwood Therapeutics (DWTX) reported total current liabilities of $2.56M in Q1 2026.
- How has Dogwood Therapeutics's total current liabilities changed year-over-year?
- Dogwood Therapeutics's total current liabilities decreased by 0.8% year-over-year, from $2.58M to $2.56M.
- What is the long-term trend for Dogwood Therapeutics's total current liabilities?
- Over 5 years (2020 to 2025), Dogwood Therapeutics's total current liabilities has grown at a 14.8% compound annual growth rate (CAGR), from $1.53M to $3.06M.
- What does total current liabilities mean?
- The sum of all obligations due within one year — payables, accrued expenses, current debt, deferred revenue, and other short-term liabilities.